CriPec® Platform and Lead Product CriPec® Docetaxel: Principles, Preparation, Biomedical...

preview_player
Показать описание
CriPec® Platform and Lead Product CriPec® Docetaxel: Principles, Preparation, Biomedical Applications and Clinical Translation

Dr. Cristianne J. F. Rijcken, PharmD, PhD, Founder and CSO, Cristal Therapeutics, Maastricht (NL)

41. Nanomedicine and Targeted Delivery – Late Breaking and Ongoing Trials
CLINAM 2018
11th European and Global Summit for Clinical
Nanomedicine, Targeted Delivery and Precision Medicine
Hall Montreal
5.9.18
  1. TAUVOD
  2. CLINAM 2018
Рекомендации по теме
CriPec® Platform and 0:16:45

CriPec® Platform and Lead Product CriPec® Docetaxel: Principles, Preparation, Biomedical...

CriPec® nanomedicines: customisable 0:01:31

CriPec® nanomedicines: customisable therapeutics to bring true benefit to patients worldwide

CriPec® Nanomedicines the 0:15:42

CriPec® Nanomedicines the Translational Path from Preclinical to Clinical Studies

CriPec Nanomedicines: Principles, 0:16:55

CriPec Nanomedicines: Principles, Preparation, Preclinical Evaluation and Early Clinical Translation

A Phase I 0:18:44

A Phase I Open‐label, Safety, Pharmacokinetic and Preliminary Efficacy Study of CriPec® Docetaxel......

12. Success Stories: 1:19:43

12. Success Stories: From Hope to Research to Findings, Products, and Therapy

LSX World Congress 0:09:24

LSX World Congress 2020 Presentations - Cristal Therapeutics

PEACE-1 points to 0:05:59

PEACE-1 points to benefit of adding abiraterone to ADT–docetaxel in de novo mCSPC | Karim Fizazi

9 Late Breaking 2:01:21

9 Late Breaking and Ongoing Trials in Nanomedicine and Tageted Delivery

Progressing the Development 0:16:07

Progressing the Development of AZD2811 Nanoparticle

The first orally 0:23:05

The first orally administered paclitaxel shown to be superior to IV paclitaxel

Taxol 0:03:07

Taxol